ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
iRadimed Corporation

iRadimed Corporation (IRMD)

55.18
-0.27
( -0.49% )
Actualizado: 11:06:28

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
55.18
Postura de Compra
54.68
Postura de Venta
55.28
Volume Operado de la Acción
9,454
54.28 Rango del Día 56.35
40.05 Rango de 52 semanas 57.95
Capitalización de Mercado [m]
Precio Anterior
55.45
Precio de Apertura
55.86
Última hora de negociación
11:06:23
Volumen financiero
US$ 520,887
Precio Promedio Ponderado
55.097
Volumen promedio (3 m)
40,768
Acciones en circulación
12,673,441
Rendimiento del Dividendo
1.09%
Ratio Precio/Utilidad
40.68
Beneficio por acción (BPA)
1.36
turnover
65.56M
Beneficio neto
17.19M

Acerca de iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion ... iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
iRadimed Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker IRMD. The last closing price for iRadimed was US$55.45. Over the last year, iRadimed shares have traded in a share price range of US$ 40.05 to US$ 57.95.

iRadimed currently has 12,673,441 shares in issue. The market capitalisation of iRadimed is US$702.74 million. iRadimed has a price to earnings ratio (PE ratio) of 40.68.

IRMD Últimas noticias

IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports GAAP diluted EPS of $0.40 and Non-GAAP diluted EPS...

IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st

WINTER SPRINGS, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the...

IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

WINTER SPRINGS, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical...

IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference

WINTER SPRINGS, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical...

IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

Reports record revenue of $17.9 million for the second quarter of 2024, an increase of 11.2 percent over the comparable period 2023.Reports GAAP diluted EPS of $0.38 and non-GAAP diluted EPS of...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.46-0.82674335010855.6457.9554.283397156.23912279CS
43.637.041707080551.5557.9546.863403352.88536132CS
1210.2322.758620689744.9557.9544.29734076849.41412215CS
2612.2228.445065176942.9657.9541.64647246.30194717CS
5212.7229.957607159742.4657.9540.054704544.93612714CS
15614.5135.677403491540.6757.95264706442.35954654CS
26031.76135.6105892423.4257.9514.4154336436.40155782CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MTEMMolecular Templates Inc
US$ 0.759117
(135.68%)
213.26M
GORVLazydays Holdings Inc
US$ 1.57
(70.65%)
3.16M
OMEROmeros Corporation
US$ 6.44
(53.70%)
10.98M
AGFYAgrify Corporation
US$ 15.20
(45.73%)
557.58k
QUBTQuantum Computing Inc
US$ 3.775
(41.92%)
138.03M
SOWGSow Good Inc
US$ 4.54
(-53.72%)
1.54M
NVCTNuvectis Pharma Inc
US$ 6.3297
(-40.68%)
1.32M
TRNRInteractive Strength Inc
US$ 3.7327
(-35.97%)
1.1M
OPRXOptimizeRx Corporation
US$ 4.12
(-33.01%)
1.21M
JTAIJet AI Inc
US$ 5.62
(-30.79%)
312.64k
ELABElevai Labs Inc
US$ 0.027699
(12.14%)
1.51B
XTIAXTI Aerospace Inc
US$ 0.0633
(10.66%)
313.86M
MTEMMolecular Templates Inc
US$ 0.751725
(133.38%)
213.5M
SVMHSRIVARU Holding Ltd
US$ 0.0274
(13.22%)
211.03M
QUBTQuantum Computing Inc
US$ 3.77
(41.73%)
138.05M
EnchantedTitan62 EnchantedTitan62 45 segundos hace
Just googled ' has Walmart had a sell rating by a major analyst in the past decade?' The AI answered 'no'. Rock on Wallyworld! Time to get outside, beautiful day.
WMT
vdog1776 vdog1776 48 segundos hace
Nope have enough shares! I’m not getting any feed back from JK anymore I’m guessing he abandoned ship?? Looks like it may be over that’s why I guessing no report coming.
VXIT
Chartmaster Chartmaster 1 minuto hace
50 Day MA turned sharply higher here the past 4 days, and volume is confirming the move! This is how stinky pinkies get started!
GRLF
LegendaryNebula4 LegendaryNebula4 1 minuto hace
We need more details for this statement: "Total pharmacy prescription and 340B contract revenues were approximately $11.5 million and $12.4 million for the three months ended September 30, 2024 and 2023, respectively, a decrease of approximately $0.8 million. The decrease was primarily due to a decr
NXPL
JohnnyRotton JohnnyRotton 1 minuto hace
5k tons will pay the money owed to complete the deals I guess.
NBRI
Pablo Bio Pablo Bio 2 minutos hace
AMRN investor conference was a waste of time and money, for the company and us. Our only hope is a reverse split, lower the share outstanding from 411 mil to whatever, this lowers the float, and keep the money on hand for AUR200,
AD has no control, he owns 35Mil, AMRN has over 411M outst
AMRN
jimmybob jimmybob 2 minutos hace
Lets see if $WYNN can get a round 2 started

- $95.65 was the gap fill from earnings
- back over the 50dma and 200dma

Past Tilman Fertitta buyouts started this exact way...
WYNN
Bountiful_Harvest Bountiful_Harvest 2 minutos hace
Kashyap Sriram@kashyap286
Analysts at Raymond James and Susquehanna raised their price target on $NVDA to $170 and $180, respectively.

Meanwhile, $SMCI, which is Nvidia's third biggest customer, is going to get delisted for accounting fraud and shine the spotlight on Nvidia's
NVDA SMCI
kaisdaboss88 kaisdaboss88 2 minutos hace
lots of loading here change of control started it seems loading continues. Updates may be coming also rdar 2.0 minus the buttchin
THBD
John Doe 2024 John Doe 2024 2 minutos hace
You have been diagnosed with TDS -Trump derangement syndrome lololololol
XERI
moosepass moosepass 2 minutos hace
How much of the float has turned over above 5 in less than a week? TIA
CGAC
cableguy cableguy 3 minutos hace
I was going to ask you but todays trading, has been to impressive so I knew it was a typo, I've been thinking there must be a group maybe on discord or an other platform other than X, don't know of any others, but the ma 50 is bearing down quickly and hard on the present PPS which (imo) should have
VHAI
chazzy1 chazzy1 3 minutos hace
DesktopDR (check your PMs).
VPLM
Dickmo Dickmo 3 minutos hace
A little quick math shows that this company sells for a PE ratio of roughly 2. Not 22, not 40. 2. Not a lot of downside here. It may not be the most liquid company yet, but the day will come when this is easily worth five to eight times more. Add in the value of PeopleVine and that could be 15
ACGX
Mark Mark 3 minutos hace
$CYTO .48, had a pop to .62, ww
CYTO
Risk Risk 3 minutos hace
I can understand the frustration here. As TJ mentioned this would have been never at this level if AFFU/Jim acted correctly and disseminate information in a timely manner.
Still we have very less shares outstanding.. hopefully we see the ascent soon
AFFU
bubba412 bubba412 3 minutos hace
Congradulations on your 1500 th top off You must have to file now as you should hold more than 5 percent of the company
ELTP
exwannabe exwannabe 3 minutos hace
Maybe NWBO already found that alternative “booster” supplier and contracted with them (see 10q), and maybe Merck (or whomever) is quite OK with that.
The BCG used in Direct manufacturing is not a "booster". It is a maturation agent that causes the PBMCs to mature into partially mature DCs.
BCG NWBO
Truth and Transparency Truth and Transparency 3 minutos hace
Another day at the slaughterhouse 🤬
NB
Truth and Transparency Truth and Transparency 3 minutos hace
Another day at the slaughterhouse 🤬
NB
Royal Dude Royal Dude 3 minutos hace
Wamu they are not allowing to see my post and am sure they are controlling us more. They will also keep pps down until they recapulize Soon Very soon HAHAHA
COOP
trunkmonk trunkmonk 3 minutos hace
there we go mate.
XRPUSD